Director, Clinical Genome Data Science
-
Science
Job Description & How to Apply Below
The Clinical Cancer Genomics Program and the Department of Pathology at the Dana‑Farber Cancer Institute (DFCI) are inviting applications for a leader in clinical genomic diagnostics to serve as Director, Clinical Genome Data Science. This is a newly created faculty leadership position within a program that is building an integrated, multi‑institutional platform for somatic and germline cancer diagnostics. Working closely with program, pathology, and disease‑area leadership, the Director will lead the development, implementation, and operation of the computational and data‑science architecture for clinical sequencing at Dana‑Farber, at the scale and rigor required for clinical care, and will help shape the scientific direction of a program positioned to advance precision cancer diagnostics nationally.
Located in Boston and the surrounding communities, Dana‑Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS, and related diseases. We strive to create an inclusive, diverse, and equitable environment where we provide compassionate and comprehensive care to patients of all backgrounds, and design programs to promote public health particularly among high‑risk and underserved populations.
We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical School‑affiliated hospitals.
The successful candidate will work with Program partners to direct genome data science across the clinical genomics platform, from primary and secondary bioinformatics through variant interpretation, automated analysis, and clinical reporting, and will integrate clinical sequencing data with DFCI’s research data infrastructure, including the Clinical Data Repositories and cBioPortal role pairs responsibility in a rigorous, high‑throughput clinical operation with close partnership on the program’s research and development agenda in emerging genomic technologies, including transcriptome‑and DNA methylation‑based classification, long‑read sequencing, measurable residual disease, and AI‑driven interpretation, working alongside the program’s Pathology Research and Development lead.
The position is based primarily at DFCI, with clinical molecular pathology responsibilities performed at affiliated partner hospitals. The academic appointment will be at Harvard Medical School, at the rank of Assistant or Associate Professor commensurate with the candidate’s credentials and experience. The Director is expected to participate in Harvard Medical School teaching and to supervise trainees and staff.
At Dana‑Farber Cancer Institute, we work every day to create an innovative, caring, and inclusive environment where every patient, family, and staff member feels they belong. As relentless as we are in our mission to reduce the burden of cancer for all, we are committed to having faculty and staff who offer multifaceted experiences. Cancer knows no boundaries and when it comes to hiring the most dedicated and compassionate professionals, neither do we.
Dana‑Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other characteristics protected by law.
Pay Transparency Statement
The hiring range is based on market pay structures, with individual salaries determined by factors such as business needs, market conditions, internal…
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).
View / Apply for Jobs
Matching My Jurisdiction